主页文献库搜索
Phylogenomics of phosphoinositide lipid kinases: perspectives on the evolutio...

Brown(James R),Auger(Kurt R) BMC Evol Biol 2011-05-18

...PIK3CA are known to be oncogenic and several inhibitors are in anti-cancer clinical trials. We found conservation of act...

High-throughput mutation profiling in intraductal papillary mucinous neoplasm...

Lubezky(Nir),Ben-Haim(Menahem),Marmor(Sylv... J Gastrointest Surg 2011-07-21

...PIK3CA mutations (low grade, 1/14; invasive, 1/7). K-ras, p53, and PIK3CA mutations present in the invasive cancer were ...

EGFR, PIK3CA and PTEN gene status and their protein product expression in neu...

Izycka-Swieszewska(Ewa),Brzeskwiniewicz(Ma... Folia Neuropathol 2011-05-04

...PIK3CA c.1060-17 C>A was significantly more frequent in extra-adrenal tumours. Polymorphism PIK3CA c.1145+54 A>G showed ...

Emerging therapeutic targets in endometrial cancer.

Dedes(Konstantin J),Wetterskog(Daniel),Ash... Nat Rev Clin Oncol 2011-09-01

...PIK3CA and FGFR2) and loss of function of genes related to DNA repair (for example PTEN) may lead to more biology-driven...

Effect of classification based on combination of mutation and methylation in ...

Aoyagi(Haruhiko),Iida(Satoru),Uetake(Hiroy... Oncol Rep 2011-05-09

...PIK3CA, respectively, in the EGFR pathway. We used the Methylight method to determine the methylation status of hMLH1, p...

PTEN restoration and PIK3CB knockdown synergistically suppress glioblastoma g...

Chen(Hongbo),Mei(Lin),Zhou(Lanzhen),Shen(X... J Neurooncol 2011-12-07

...PIK3CA on PTEN-deficient glioblastoma cells in vitro and in subcutaneous xenografts. Restoration of PTEN or knockdown of...

Preclinical pharmacology, antitumor activity, and development of pharmacodyna...

Yap(Timothy A),Walton(Mike I),Hunter(Lisa-... Mol Cancer Ther 2011-10-14

...PIK3CA-mutant BT474 human breast cancer xenografts, consistent with its pharmacokinetic and pharmacodynamic properties. ...

Tissue-specific signatures of activating PIK3CA and RAS mutations in carcinos...

Growdon(Whitfield B),Roussel(Breton N),Sci... Gynecol Oncol 2011-05-16

...PIK3CA (19%), KRAS (15%), CTNNB1 (4%) and NRAS (2%). Mutation in a single gene was observed in 31% of patient samples, w...

Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, ...

Baba(Yoshifumi),Nosho(Katsuhiko),Shima(Kao... Cancer 2011-05-03

...PIK3CA, KRAS, BRAF, microsatellite instability (MSI), CpG island methylator phenotype (CIMP), LINE-1 methylation, TP53 (...

EGFR related mutational status and association to clinical outcome of third-l...

Spindler(Karen-Lise G),Pallisgaard(Niels),... BMC Cancer 2011-06-21

As supplement to KRAS mutational analysis, BRAF and PIK3CA mutations as well as expression of PTEN may account for addit...

上一页 249 250 251 252 253 254 255 256 257 下一页 253 / 共 350

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com